U.S. Specialized REITs Stock News

The market shaved about 2.8% off Trulieve Cannabis stock today, yet the headline from this quarter is not a demand problem. The story is the hit to reported earnings from the Harvest deconsolidation and the way it distorts the income statement. Trulieve posted a reported net loss of about US$406 million for Q2 on revenue of US$271 million. However, management pointed to roughly US$20 million of underlying net income once the one time Harvest impact is stripped out. For a medical cannabis...

Axalta Coating Systems stock after earnings and guidance update Axalta Coating Systems (AXTA) recently reported second quarter 2026 results alongside fresh guidance, giving investors new data on revenue trends, profit pressures and expectations for low single digit net sales growth this year. See our latest analysis for Axalta Coating Systems. The recent earnings update, guidance for low single digit net sales growth and the August 5 bylaw change on merger approvals have coincided with a...

Why Dana stock is back in focus after new guidance Dana (DAN) moved back onto investors' radar after the company lifted its full year 2026 sales outlook by about $225 million and reaffirmed active share buybacks, despite reporting a quarterly net loss. See our latest analysis for Dana. The upgraded 2026 sales guidance and ongoing buybacks have coincided with a 1 day share price return of 4.10% and a 7 day share price return of 5.61%, even though the 90 day share price return is down 16.01%...

What Aehr Test Systems’ New Shelf Registration Means For Investors Aehr Test Systems (AEHR) has filed an omnibus shelf registration that covers potential future issuances of common and preferred stock, debt securities, depositary shares, warrants, subscription rights, and units. This filing gives Aehr Test Systems flexibility to raise capital when conditions suit its plans rather than arranging a separate registration each time it wants to issue securities. See our latest analysis for Aehr...

Talos Energy Inc. recently reported second-quarter 2026 results, with revenue of US$664.81 million, net income of US$149.67 million, and average net daily production of 93.7 MBoe/d, while also updating its 2026 production guidance. At the same time, Talos filed a US$77.06 million shelf registration for 5.4 million common shares tied to an ESOP offering and confirmed it has completed a multi-year buyback totaling 22,676,655 shares. We’ll now examine how Talos’s sharp swing to quarterly...

In early August 2026, Seadrill Limited reported its second-quarter 2026 results against a backdrop of volatile oil and gas markets driven by geopolitical tensions involving Iran. The report drew particular attention because higher oil prices have recently tended to support upstream spending, putting a spotlight on how Seadrill’s offshore drilling business is positioned within this shifting sector backdrop. We’ll now examine how Seadrill’s latest earnings, released amid heightened oil price...

Target stock has rallied strongly so far in 2026, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares trade at a premium while earnings based multiples still screen as relatively cheap. Year to date, Target has returned 48.9%, which puts extra focus on whether recent gains are already pricing in a fuller recovery story. Expectations around Target’s ongoing recovery in sales and profitability can support the current share...

Why agilon health’s latest earnings matter for investors agilon health (AGL) moved into the spotlight after reporting second quarter results that shifted from a net loss to a profit, accompanied by higher full year revenue guidance for 2026. The company’s earnings update on 5 August 2026 also drew attention to risks related to leadership changes and heavy reliance on a small number of payers, which could influence membership growth and the economics of key contracts. See our latest analysis...

In early August 2026, AppLovin reported past second-quarter 2026 results showing revenue of US$1.92 billion and net income of US$1.27 billion, alongside guidance for third-quarter revenue between US$2.06 billion and US$2.09 billion and disclosure that its multi-year share repurchase program had retired 22.8% of shares outstanding. Beyond the headline growth, the conclusion of an SEC inquiry with no recommended action and record advertiser spend highlighted both regulatory clarity and strong...

AbCellera Biologics recently released top-line Phase 2 data for ABCL635, a potential first-in-class non-hormonal NK3R-targeting antibody for moderate-to-severe menopausal vasomotor symptoms, from a randomized, double-blind, placebo-controlled trial of about 80 postmenopausal women, and discussed the results on an investor call. This marks the first clinical readout from AbCellera’s GPCR and ion channel platform, offering an early test of its shift toward developing internal therapeutic...

Why Mueller Water Products Stock Is Back On Investor Radar Mueller Water Products (MWA) is drawing fresh attention after reporting higher third quarter sales, net income and earnings per share, alongside tighter full year net sales guidance that points to expected growth. See our latest analysis for Mueller Water Products. At a share price of $26.65, Mueller Water Products has seen its short term share price return soften slightly in the last day, although the 7 day and 30 day share price...

Pegasystems Inc. recently expanded the FedRAMP Class D Certified capabilities of its Pega Cloud for Government, adding AI-powered workflow automation, decisioning, and process optimization tools that federal agencies can now use for mission-critical, highly sensitive workloads on AWS GovCloud. This certification expansion is significant because it positions Pega’s platform as a compliant way for government clients to scale advanced AI and case management across complex, high-impact...

Willis Lease Finance (WLFC) has agreed to purchase three commercial buildings in Coconut Creek, Florida, for US$118.0 million. The acquisition is directly tied to its expanding headquarters, spare parts, maintenance, and engine storage operations. See our latest analysis for Willis Lease Finance. The recent purchase agreement and new engine storage deal with Pratt & Whitney come after a sharp pullback, with Willis Lease Finance’s share price falling around 18% over the past month despite a...

Yum! Brands stock has returned 22.7% over the past five years, yet current checks suggest it now trades close to its estimated intrinsic value rather than standing out as a clear bargain. The Discounted Cash Flow (DCF) intrinsic value estimate points to the shares being roughly fairly valued, and the broader valuation framework leans slightly expensive. Over the last 5 years, Yum! Brands has delivered a 22.7% total return, which sets expectations for what investors may reasonably want to see...

Inflation expectations in major economies are shifting again, and central banks keep stressing the role of wages and labor shortages. That puts robotics and automation center stage because companies are searching for ways to raise output without relying only on hiring. For investors, this creates a focused hunting ground. This article looks at 3 robotics and automation leaders from our screener that stand out in this backdrop. The 3 stocks highlighted below are just a first pass. The full...

SkyWater Technology walked into this earnings print with a flat tape and a stock that has gone nowhere over the past week, yet quietly carried a low 13.6x trailing P/E in a sector where peers trade much richer. The headline today is not the Q2 loss of US$6.4 million on US$156.4 million of revenue. The real story is that SkyWater now shows trailing 12 month profitability while the market still prices in weak interest coverage and soft forward expectations. The lack of immediate price reaction...

Clover Health Investments, Corp. reported second-quarter 2026 results showing net income of US$28 million versus a US$10.58 million loss a year earlier, with basic and diluted earnings per share from continuing operations improving to US$0.05 from a US$0.02 loss. For the first half of 2026, Clover Health generated US$55.34 million in net income and, on the same day, raised its full-year 2026 revenue and GAAP net income guidance, signaling materially higher expectations for both top-line and...

AXIS Capital Holdings (AXS) has been active on the corporate front, with recent leadership appointments and fresh earnings data giving investors new information to assess how the stock fits within their portfolio. See our latest analysis for AXIS Capital Holdings. Recent news around AXIS Capital Holdings, including the Q2 2026 earnings update, incremental share buybacks and leadership hires in wholesale underwriting and AI strategy, has arrived alongside a 30 day share price return that is...

Kimbell Royalty Partners (KRP) is back in focus after reporting record second quarter 2026 revenue and net income, lifting its cash distribution by 15% and highlighting continued acquisition opportunities alongside increased credit capacity. See our latest analysis for Kimbell Royalty Partners. The latest earnings and distribution news comes after a strong run in Kimbell Royalty Partners’ share price, with a year to date share price return of 24.52% and a 5 year total shareholder return of...

Cisco Systems (CSCO) is drawing fresh attention after raising its hyperscaler AI infrastructure order target to US$9b for fiscal 2026 and outlining plans to recognize about US$4b of that as revenue. See our latest analysis for Cisco Systems. The AI order update comes after a strong run in Cisco Systems' stock, with a 90 day share price return of 25.74% and a year to date share price return of 59.69%. The 1 year total shareholder return of 72.65% points to momentum that has built over time as...

This week’s inflation and retail sales data puts income focused portfolios under the spotlight, as investors weigh stubborn prices, rate hike risk and the strain on household budgets. That mix can leave some stocks exposed, and others quietly better positioned. This article looks at three high quality dividend growth stocks from our screener that appear more resilient to these cross currents and explains what the latest data could mean for their income profiles. The three stocks covered below...

In early August 2026, Qfin Holdings Inc. entered its June-quarter earnings season with analysts expecting year-over-year declines in both revenue and earnings, even as consensus EPS forecasts were revised slightly higher and Zacks assigned the stock a favorable Rank #2 alongside an Earnings ESP of 5.58%. At the same time, options markets began pricing in a large potential move in Qfin’s shares, suggesting traders are bracing for significant post-earnings volatility as analysts grow somewhat...

Why QuantumScape’s Q2 Pivot Matters For Investors QuantumScape (QS) has unsettled some investors with its Q2 update. The company is shifting from building battery factories to licensing its solid state technology, while pushing its commercial readiness timeline out to 2029. This change in direction, combined with the continued absence of revenue, has become a key focus for anyone tracking QuantumScape stock and reassessing the risk profile around its long term electric vehicle battery...

In the past week, Definium Therapeutics, Inc. reported a wider Q2 2026 net loss of US$158.99 million with basic and diluted loss per share of US$1.44, while also highlighting strong Phase III DT120 ODT data in major depressive disorder and progress toward pivotal generalized anxiety disorder readouts. The company also released a large real‑world claims analysis showing high discontinuation and switching rates in generalized anxiety disorder treatment, underscoring substantial unmet need that...